Detalhe da pesquisa
1.
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Support Care Cancer
; 30(9): 7469-7479, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657402
2.
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
Br J Haematol
; 192(3): e73-e77, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236352
3.
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
Leuk Lymphoma
; 64(8): 1465-1471, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259553
4.
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.
Leuk Lymphoma
; 63(10): 2489-2493, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35570744
5.
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.
Leuk Lymphoma
; 62(12): 3023-3026, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162310
6.
Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience.
Leuk Lymphoma
; 62(14): 3544-3547, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348069